TRIAZABENZO (A)NAPHTHO(2,1,8-CDE) AZULENE COMPOUNDS.
申请人:Brion Jean-Daniel
公开号:US20100105666A1
公开(公告)日:2010-04-29
Compounds of formula (I):
wherein:
R
1
represents hydrogen, (C
1
-C
6
)alkyl, (C
1
-C
6
)aminoalkyl or (C
1
-C
6
)hydroxyalkyl,
R
2
represents hydrogen,
or R
1
and R
2
, together with the carbon atoms carrying them, form a carbon-carbon bond,
R
3
represents hydrogen,
R
4
represents hydrogen, methyl or (C
3
-C
6
)alkyl, (C
1
-C
6
)aminoalkyl, (C
1
-C
6
)hydroxyalkyl, aryl-(C
1
-C
6
)alkyl or heterocycloalkyl-(C
1
-C
6
)alkyl,
or R
3
and R
4
together with the carbon atoms carrying them, form a carbon-carbon bond,
R
5
, R
6
, R
7
and R
8
represent hydrogen,
or a pair of geminal substituents (R
5
and R
6
and/or R
7
and R
8
) form an oxo, thioxo or imino group,
R
9
represents hydrogen, halogen, (C
1
-C
6
)alkyl, (C
1
-C
6
)alkoxy, hydroxy, cyano, nitro, (C
1
-C
6
)polyhaloalkyl or optionally substituted amino,
R
10
and R
11
represent hydrogen, halogen, (C
1
-C
6
)alkyl, (C
1
-C
6
)alkoxy, hydroxy, cyano, nitro, (C
1
-C
6
)polyhaloalkyl or optionally substituted amino,
n represents an integer between 0 and 4 inclusive,
m represents an integer between 0 and 2 inclusive,
p represents an integer between 0 and 3 inclusive,
X represents a group NR
12
,
R
12
represents hydrogen, (C
1
-C
6
)alkyl, (C
2
-C
6
)alkenyl, aryl-(C
1
-C
6
)alkyl or (C
1
-C
6
)polyhaloalkyl,
their enantiomers, diastereoisomers and N-oxides, and also addition salts thereof with a pharmaceutically acceptable acid or base.
式(I)的化合物:
其中:
R1代表氢、(C1-C6)烷基、(C1-C6)氨基烷基或(C1-C6)羟基烷基,
R2代表氢,或者R1和R2连同携带它们的碳原子形成碳-碳键,
R3代表氢,
R4代表氢、甲基或(C3-C6)烷基、(C1-C6)氨基烷基、(C1-C6)羟基烷基、芳基-(C1-C6)烷基或杂环烷基-(C1-C6)烷基,或者R3和R4连同携带它们的碳原子形成碳-碳键,
R5、R6、R7和R8代表氢,或者一对同位素取代基(R5和R6和/或R7和R8)形成氧化、硫化或亚胺基团,
R9代表氢、卤素、(C1-C6)烷基、(C1-C6)烷氧基、羟基、氰基、硝基、(C1-C6)多卤代烷基或可选择取代的氨基,
R10和R11代表氢、卤素、(C1-C6)烷基、(C1-C6)烷氧基、羟基、氰基、硝基、(C1-C6)多卤代烷基或可选择取代的氨基,
n为0到4之间的整数,
m为0到2之间的整数,
p为0到3之间的整数,
X代表一个NR12基团,
R12代表氢、(C1-C6)烷基、(C2-C6)烯基、芳基-(C1-C6)烷基或(C1-C6)多卤代烷基,
它们的对映异构体、顺反异构体和N-氧化物,以及其与药用酸或碱形成的加合盐。